Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Mehta

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
American Journal of Nephrology|December 6, 2021
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE TrialJoão Pedro Ferreira, Patrick Rossignol, George Bakris, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trialJoão Pedro Ferreira, Zohra Lamiral, George Bakris, et al.
Circulation|February 4, 2009
Optimizing trial design: sequential, adaptive, and enrichment strategiesCyrus Mehta, Ping Gao, Deepak L Bhatt, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2020
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trialJoão Pedro Ferreira, Abhinav Sharma, Cyrus Mehta, et al.
American Heart Journal|September 11, 2020
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitusMalik Elharram, Abhinav Sharma, William White, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2021
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndromeXavier Rossello, João Pedro Ferreira, Francisca Caimari, et al.
Journal of the American Heart Association|October 30, 2018
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE TrialWilliam B White, Fatima Jalil, William C Cushman, et al.
Circulation|October 26, 2018
Reassessing the Role of Surrogate End Points in Drug Development for Heart FailureStephen J Greene, Robert J Mentz, Mona Fiuzat, et al.
Diabetes, Obesity & Metabolism|October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trialYou-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
American Journal of Nephrology|December 6, 2021
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE TrialJoão Pedro Ferreira, Patrick Rossignol, George Bakris, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trialJoão Pedro Ferreira, Zohra Lamiral, George Bakris, et al.
Circulation|February 4, 2009
Optimizing trial design: sequential, adaptive, and enrichment strategiesCyrus Mehta, Ping Gao, Deepak L Bhatt, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2020
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trialJoão Pedro Ferreira, Abhinav Sharma, Cyrus Mehta, et al.
American Heart Journal|September 11, 2020
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitusMalik Elharram, Abhinav Sharma, William White, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2021
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndromeXavier Rossello, João Pedro Ferreira, Francisca Caimari, et al.
Journal of the American Heart Association|October 30, 2018
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE TrialWilliam B White, Fatima Jalil, William C Cushman, et al.
Circulation|October 26, 2018
Reassessing the Role of Surrogate End Points in Drug Development for Heart FailureStephen J Greene, Robert J Mentz, Mona Fiuzat, et al.
Diabetes, Obesity & Metabolism|October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trialYou-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Pageof 4